Design Therapeutics Inc
NASDAQ:DSGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Design Therapeutics Inc
NASDAQ:DSGN
|
US |
|
Redcentric PLC
LSE:RCN
|
UK |
|
Future Battery Minerals Ltd
ASX:FBM
|
AU |
|
Smith Micro Software Inc
NASDAQ:SMSI
|
US |
|
Harris Technology Group Ltd
ASX:HT8
|
AU |
|
Eguana Technologies Inc
XTSX:EGT
|
CA |
|
SDI Ltd
ASX:SDI
|
AU |
|
Country Garden Holdings Co Ltd
OTC:CTRYY
|
CN |
|
J
|
John Menzies PLC
XBER:B3N
|
UK |
|
Y
|
YC Corp
KOSDAQ:232140
|
KR |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
SA |
|
P
|
Paz Corp SA
SGO:PAZ
|
CL |
Shareholder Yield
Current shareholder yield for DSGN is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DSGN Price
Design Therapeutics Inc
| Average Annual Return | -0.41% |
| Standard Deviation of Annual Returns | 98.37% |
| Max Drawdown | -93% |
| Market Capitalization | 734.4m USD |
| Shares Outstanding | 61 670 000 |
| Percentage of Shares Shorted | 4.63% |
